Human serum amyloid protein is a acute phase reactant and a marker of inflammation due to tissue damage or trauma. Higher levels are associated with inflammatory or autoimmune diseases, secondary amyloidosis and viral infections. It serves as a predictor of acute renal allograft rejection as well as an indicator of rheumatoid arthritis and tuberculosis. The test can aid in predicting inflammatory responses and modifying inflammatory treatment.